King® Guide to Parenteral Admixtures®
Loose-Leaf Edition
The Original Standard in Hospital Pharmacy Since 1971
Providing the most up-to-date, complete and innovative injectable drug compatibility and stability information in hospital pharmacy worldwide, the King Guide is a proven, authoritative resource for pharmacists, nurses, physicians and other practitioners involved in the preparation and administration of intravenous drugs.
"This is the most updated information on parenteral admixtures on the market."
IJPC Vol.5 No.4 July/August 2001.
Features
- Updated Quarterly Since 1971
- Exceeds TJC Requirements
- NABP Endorsed
- Over 600 IV drugs with at-a-glance view of compatibility in 12 fluids
- Over 3,200 Primary Source References
- Includes routes, dosages, temperatures, and containers used to determine compatibility and stability.
- Y-Site, Syringe, and other sets/container specific information.
- Extensive TPN/TNA data.
- Special Sections on Stability and Storage
- Boxed Warning and Hazardous Drugs List and Identification
- Proprietary and Generic Drug Names Included
Summer 2024
In this update we added a new monograph for DURVALUMAB.
We also added new stability information to the monographs for CARMUSTINE, CETUXIMAB, CISATRACURIUM BESYLATE, MITOMYCIN, PEMETREXED, and THIOTEPA.
New compatibility information was added to the existing drug monographs for ALPROSTADIL, AMPICILLIN SODIUM, AMPICILLIN SODIUM – SULBACTAM SODIUM, BUMETANIDE, CEFOTAXIME SODIUM, CEFTRIAXONE, DEXMEDETOMIDINE HYDROCHLORIDE, DIHYDROERGOTAMINE MESYLATE, DOPAMINE HYDROCHLORIDE, FUROSEMIDE, HEPARIN SODIUM, HYDROMORPHONE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE, LACOSAMIDE, MORPHINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, POTASSIUM CHLORIDE, ROCURONIUM BROMIDE, SILDENAFIL CITRATE, TOTAL PARENTERAL NUTRITION SOLUTIONS, VANCOMYCIN HYDROCHLORIDE, and VASOPRESSIN.